{"disease":{"id":"non-cystic-fibrosis-bronchiectasis","name":"non-cystic fibrosis bronchiectasis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":2},"drugs":{"marketed":[{"drug_id":"brensocatib","indication_name":"non-cystic fibrosis bronchiectasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brinsupri","generic_name":"BRENSOCATIB","company_name":"Insmed Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Brinsupri works by inhibiting the activity of a protein that contributes to airway damage and inflammation."},{"drug_id":"brensocatib","indication_name":"non-cystic fibrosis bronchiectasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brinsupri","generic_name":"BRENSOCATIB","company_name":"Insmed Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Brinsupri works by inhibiting the activity of a protein that contributes to airway damage and inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04594369","title":"A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1767,"lead_sponsor_name":"Insmed Incorporated","has_results":true},{"nct_id":"NCT06660992","title":"A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":669,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT07048262","title":"Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT06715956","title":"Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT03093974","title":"Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":377,"lead_sponsor_name":"Zambon SpA","has_results":true},{"nct_id":"NCT07245407","title":"A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE","phase":"","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03460704","title":"Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":287,"lead_sponsor_name":"Zambon SpA","has_results":true},{"nct_id":"NCT03218917","title":"Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Insmed Incorporated","has_results":true},{"nct_id":"NCT06981091","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":231,"lead_sponsor_name":"S-INFINITY Pharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT05601778","title":"A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT02088216","title":"Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis","phase":"NA","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":true},{"nct_id":"NCT06877091","title":"Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)","phase":"","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT06603246","title":"A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT02712983","title":"Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05006573","title":"Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":100,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07547436","title":"A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04010799","title":"A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":false},{"nct_id":"NCT04643587","title":"Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT06663176","title":"Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Thirty Respiratory Limited","has_results":false},{"nct_id":"NCT06237348","title":"Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Physio-Assist","has_results":false},{"nct_id":"NCT05860803","title":"Breathing Training and Exercise Capacity in Non-CFB","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05616221","title":"Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Armata Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04322929","title":"Roflumilast in Non-CF Bronchiectasis Study (2019)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06164470","title":"Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05495243","title":"Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Renovion, Inc.","has_results":false},{"nct_id":"NCT05523180","title":"A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life","phase":"NA","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"ResBiotic Nutrition, Inc.","has_results":false},{"nct_id":"NCT05369624","title":"Exercise Capacity in Non-cystic Fibrosis Bronchiectasis After a Pulmonary Rehabilitation Home-based Program","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Hospital Universitario Virgen Macarena","has_results":false},{"nct_id":"NCT05743946","title":"Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT07376187","title":"Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"University of Thessaly","has_results":false},{"nct_id":"NCT03428334","title":"Roflumilast in Non-CF Bronchiectasis Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04278040","title":"Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":7,"lead_sponsor_name":"Federal State Budgetary Institution, Pulmonology Scientific Research Institute","has_results":false},{"nct_id":"NCT04656275","title":"A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT05344508","title":"An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Insmed Incorporated","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}